Utility of chromogranin B compared with chromogranin A as a biomarker in Japanese patients with pancreatic neuroendocrine tumors

OBJECTIVE: Currently, serum chromogranin A is a well-established biomarker for pancreatic neuroendocrine tumors; however, other pancreatic diseases, oral use of a proton pump inhibitor and renal impairment can affect chromogranin A. Meanwhile, chromogranin B, belonging to the same granin family as c...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Jpn J Clin Oncol
Hlavní autoři: Miki, Masami, Ito, Tetsuhide, Hijioka, Masayuki, Lee, Lingaku, Yasunaga, Kohei, Ueda, Keijiro, Fujiyama, Takashi, Tachibana, Yuichi, Kawabe, Ken, Jensen, Robert T., Ogawa, Yoshihiro
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2017
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6283109/
https://ncbi.nlm.nih.gov/pubmed/28334992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyx032
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky